Premium
Sativex: oromucosal cannabinoid spray for spasticity in MS
Author(s) -
Chaplin Steve,
Dobson Ruth
Publication year - 2010
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.684
Subject(s) - spasticity , medicine , multiple sclerosis , cannabinoid , clinical efficacy , physical therapy , physical medicine and rehabilitation , surgery , psychiatry , receptor
Sativex is an oromucosal cannabinoid spray licensed as add‐on therapy for moderate to‐severe spasticity in multiple sclerosis. In our New products review Steve Chaplin presents the clinical data relating to its efficacy and side‐effects, and Dr Ruth Dobson discusses its place in the treatment of spasticity.